Cellebrite DI reported strong Q1 FY24 results with revenue up 26% YoY, ARR at $331.8 million, and EPS beating consensus. Outlook remains positive with expected revenue of $90M-$94M in Q2 and $370M-$380M for FY24.
Xiaomi reported a 27% revenue increase for Q1 2024, reaching RMB75.51 billion. The company's global smartphone shipments rose 33.7% to 40.6 million units, while IoT devices on Xiaomi's AIoT platform surged 27.2% to 786.1 million. Despite a 1% net income decline, signs of recovery in the mobile market are evident. Xiaomi aims to deliver 120,000 SU7 electric vehicles this year.
Monro reported fourth-quarter adjusted earnings per share of 21 cents, missing the analyst consensus of 30 cents. Quarterly revenues of $310.08 million missed the street view of $320.239 million. Sales for the fourth quarter decreased 0.2%.
Medtronic reported Q4 2024 sales of $8.59 billion, with 0.5% reported and 5.4% organic revenue growth. Dividend increased to $0.70 per share. FY 2025 EPS guidance is $5.40-$5.50.
Triumph Group reported strong Q4 FY24 results with sales of $358.6M (+11% Y/Y) and adjusted EPS of $0.31, beating estimates. The backlog increased by 22% and the company expects improvement in financial metrics.
Ralph Lauren reported a 2% year-on-year increase in fourth-quarter FY24 sales to $1.568 billion, surpassing the analyst estimate of $1.563 billion. Global direct-to-consumer comparable store sales grew by 6%. The company's gross profit reached $1 billion with a margin of 66.6%. Operating income soared 168% to $107.8 million. Adjusted EPS of $1.71 beat the consensus estimate of $1.66.